CLINICAL_TRIALS
trial_result
· 2021-08-27
Clinical Trial Update: Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH) [Phase 4]
Summary
Phase 4 study evaluating how renal function affects the pharmacokinetics of SIKLOS (DARH) in sickle cell disease; completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theravia | Conditions: Sickle Cell Disease, Renal Function Disorder | Phase 4 | Status: COMPLETED | Results posted: 2021-08-27